Bronchoalveolar Lavage and Response to Cyclophosphamide in Scleroderma Interstitial Lung Disease

類似資料

• Cyclophosphamide for Systemic Sclerosis-Related Interstitial Lung Disease: A Comparison of Scleroderma Lung Studies I and II
  著者:: Volkmann, Elizabeth R., 等
  出版事項: (2019)
• Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease
  著者:: Tashkin, Donald P., 等
  出版事項: (2007)
• Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo: Findings From the Scleroderma Lung Study
  著者:: Goldin, Jonathan, 等
  出版事項: (2009)
• Predicting Treatment Outcomes and Responder Subsets in Scleroderma-related Interstitial Lung Disease
  著者:: Roth, Michael D., 等
  出版事項: (2011)
• Correlation of Cough With Disease Activity and Treatment With Cyclophosphamide in Scleroderma Interstitial Lung Disease: Findings From the Scleroderma Lung Study
  著者:: Theodore, Arthur C., 等
  出版事項: (2012)